Economic Evaluation of Interventions to Prevent Healthcare-Associated Infections in the VA

by Richard Nelson, Ph.D.
Seminar date: 6/14/2016

Description: Following the implementation of the VA MRSA Prevention Initiative in October 2007, the rate of methicillin-resistant Staphylococcus aureus (MRSA) healthcare-associated infections (HAIs) decreased substantially. In order to evaluate whether these benefits were sufficient to warrant the cost of this extensive intervention, it is important to have accurate estimates of the consequences of MRSA HAIs. This presentation will describe our efforts to generate these estimates as well as the results from an economic evaluation the initiative. Dr. Michael Rubin, Section Chief of Epidemiology at VA Salt Lake City Health Care System, will be on the call as a discussant and available for Q&A with the audience. Intended audience: CDAs, health economists, ID service providers and others.

DOWNLOAD: Request PDF Handout | Audio only (mp3) | transcript

Questions about the HSR website? Email the Web Team

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.